Invesco’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $164M | Buy |
823,604
+307,140
| +59% | +$60.8M | 0.02% | 722 |
|
|
2025
Q4 | $97.6M | Buy |
516,464
+138,169
| +37% | +$26.5M | 0.01% | 840 |
|
|
2025
Q3 | $67M | Buy |
378,295
+148,437
| +65% | +$22.1M | 0.01% | 975 |
|
|
2025
Q2 | $26.1M | Buy |
229,858
+27,030
| +13% | +$2.89M | ﹤0.01% | 1311 |
|
|
2025
Q1 | $21.3M | Buy |
202,828
+8,473
| +4% | +$958K | ﹤0.01% | 1408 |
|
|
2024
Q4 | $20.8M | Buy |
194,355
+5,627
| +3% | +$636K | ﹤0.01% | 1465 |
|
|
2024
Q3 | $18.9M | Buy |
188,728
+15,917
| +9% | +$1.6M | ﹤0.01% | 1487 |
|
|
2024
Q2 | $14.6M | Sell |
172,811
-42,284
| -20% | -$3.36M | ﹤0.01% | 1590 |
|
|
2024
Q1 | $15.7M | Buy |
215,095
+194
| +0.1% | +$14.3K | ﹤0.01% | 1567 |
|
|
2023
Q4 | $15.3M | Sell |
214,901
-3,886
| -2% | -$229K | ﹤0.01% | 1558 |
|
|
2023
Q3 | $13.1M | Sell |
218,787
-3,196
| -1% | -$210K | ﹤0.01% | 1585 |
|
|
2023
Q2 | $16M | Sell |
221,983
-4,120
| -2% | -$309K | ﹤0.01% | 1492 |
|
|
2023
Q1 | $16.6M | Sell |
226,103
-783
| -0.3% | -$55.7K | ﹤0.01% | 1446 |
|
|
2022
Q4 | $15.2M | Sell |
226,886
-79,401
| -26% | -$5.16M | ﹤0.01% | 1540 |
|
|
2022
Q3 | $16.5M | Sell |
306,287
-44,825
| -13% | -$2.64M | 0.01% | 1456 |
|
|
2022
Q2 | $19.5M | Buy |
351,112
+39,223
| +13% | +$2.23M | 0.01% | 1389 |
|
|
2022
Q1 | $21.9M | Sell |
311,889
-23,157
| -7% | -$1.68M | 0.01% | 1456 |
|
|
2021
Q4 | $32.3M | Sell |
335,046
-99,962
| -23% | -$9.23M | 0.01% | 1246 |
|
|
2021
Q3 | $37.8M | Buy |
435,008
+53,996
| +14% | +$4.18M | 0.01% | 1172 |
|
|
2021
Q2 | $31.2M | Buy |
381,012
+59,181
| +18% | +$4.92M | 0.01% | 1333 |
|
|
2021
Q1 | $30.6M | Buy |
321,831
+11,144
| +4% | +$1.05M | 0.01% | 1299 |
|
|
2020
Q4 | $19.3M | Buy |
310,687
+14,802
| +5% | +$844K | 0.01% | 1450 |
|
|
2020
Q3 | $17.6M | Buy |
295,885
+45,751
| +18% | +$3.12M | 0.01% | 1370 |
|
|
2020
Q2 | $17.5M | Buy |
250,134
+9,210
| +4% | +$584K | 0.01% | 1339 |
|
|
2020
Q1 | $10.9M | Sell |
240,924
-78,002
| -24% | -$4.42M | ﹤0.01% | 1490 |
|
|
2019
Q4 | $20.7M | Buy |
318,926
+270,943
| +565% | +$18.1M | 0.01% | 1411 |
|
|
2019
Q3 | $2.98M | Sell |
47,983
-540,339
| -92% | -$33.9M | ﹤0.01% | 2415 |
|
|
2019
Q2 | $41.9M | Buy |
588,322
+521,413
| +779% | +$38.4M | 0.01% | 1095 |
|
|
2019
Q1 | $5.25M | Sell |
66,909
-136,948
| -67% | -$10.4M | ﹤0.01% | 1976 |
|
|
2018
Q4 | $17.3M | Sell |
203,857
-505,560
| -71% | -$53.9M | 0.01% | 1213 |
|
|
2018
Q3 | $121M | Buy |
709,417
+235,912
| +50% | +$35.6M | 0.04% | 503 |
|
|
2018
Q2 | $61.2M | Buy |
473,505
+119,335
| +34% | +$13.3M | 0.02% | 755 |
|
|
2018
Q1 | $36.5M | Buy |
354,170
+16,711
| +5% | +$1.65M | 0.01% | 883 |
|
|
2017
Q4 | $28.8M | Buy |
337,459
+17,590
| +5% | +$1.52M | 0.01% | 1011 |
|
|
2017
Q3 | $27.2M | Sell |
319,869
-28,812
| -8% | -$2.28M | 0.01% | 1045 |
|
|
2017
Q2 | $26.4M | Sell |
348,681
-222,925
| -39% | -$15.6M | 0.01% | 1066 |
|
|
2017
Q1 | $37.7M | Sell |
571,606
-89,135
| -13% | -$5.86M | 0.01% | 917 |
|
|
2016
Q4 | $41.9M | Sell |
660,741
-135,145
| -17% | -$8.53M | 0.01% | 870 |
|
|
2016
Q3 | $50.7M | Buy |
795,886
+39,089
| +5% | +$2.87M | 0.02% | 750 |
|
|
2016
Q2 | $56.3M | Sell |
756,797
-159,332
| -17% | -$11.8M | 0.02% | 705 |
|
|
2016
Q1 | $61.2M | Sell |
916,129
-270,213
| -23% | -$16.4M | 0.02% | 647 |
|
|
2015
Q4 | $80.2M | Sell |
1,186,342
-271,083
| -19% | -$16.7M | 0.03% | 590 |
|
|
2015
Q3 | $77.9M | Sell |
1,457,425
-60,648
| -4% | -$3.68M | 0.03% | 573 |
|
|
2015
Q2 | $95.6M | Sell |
1,518,073
-330,271
| -18% | -$18M | 0.04% | 531 |
|
|
2015
Q1 | $88.9M | Buy |
1,848,344
+390,541
| +27% | +$15M | 0.03% | 554 |
|
|
2014
Q4 | $48.4M | Buy |
1,457,803
+175,331
| +14% | +$5.7M | 0.02% | 812 |
|
|
2014
Q3 | $37.6M | Buy |
1,282,472
+408,651
| +47% | +$13.6M | 0.02% | 928 |
|
|
2014
Q2 | $34M | Sell |
873,821
-154,980
| -15% | -$6.29M | 0.01% | 994 |
|
|
2014
Q1 | $43.2M | Buy |
1,028,801
+172,857
| +20% | +$7.21M | 0.02% | 854 |
|
|
2013
Q4 | $28.1M | Buy |
855,944
+77,360
| +10% | +$2.52M | 0.01% | 1073 |
|
|
2013
Q3 | $21M | Sell |
778,584
-156,813
| -17% | -$4.41M | 0.01% | 1140 |
|
|
2013
Q2 | $21.8M | Buy |
+935,397
| New | +$16.8M | 0.01% | 1069 |
|
Other funds holding LGND
VPM
VCM
NAMI
CC
Invesco's LGND Position: Q1 2026 in Review
Invesco increased its Ligand Pharmaceuticals (LGND) stake by 59% in Q1 2026, buying an estimated $60.8M and bringing the position to 823,604 shares worth $164M. The position accounts for 0.02% of the portfolio, ranked #722.
Invesco first reported a position in LGND in Q2 2013 and has held it in 52 quarters since. 357 funds tracked by Wall St. Rank hold LGND as of Q1 2026.
- Invesco held 823,604 shares of Ligand Pharmaceuticals worth $164M as of Q1 2026.
- Invesco bought 307,140 Ligand Pharmaceuticals shares in Q1 2026, an estimated $60.8M.
- Ligand Pharmaceuticals made up 0.02% of Invesco's portfolio in Q1 2026, its #722 holding.
- Invesco first reported a position in Ligand Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
- 357 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q1 2026.
Based on Invesco's 13F filing for Q1 2026, filed 12 May 2026.